Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coal tar added to topical corticosteroids for moderate to severe atopic dermatitis
2016-004687-19Phase 4Terminated
- Sponsor
- Radboud University Medical Center
- Start
- Jan 2017
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of coal tar, betamethasone and hydrocortisone in atopic dermatitis (AD) (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Percentage change in EASI score at week 2. Started Jan 2017; status: terminated.
02
Drugs
coal tarbetamethasonehydrocortisone
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2016-004687-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004687-19.